Parkinson's Disease Stocks List

Parkinson's Disease Stocks Recent News

Date Stock Title
Apr 19 ITCI How Is The Market Feeling About Intra-Cellular Therapies?
Apr 19 TEVA Alvotech/Teva bring new partner to expand access for Humira biosimilar in U.S.
Apr 19 TEVA Zacks Industry Outlook Highlights Teva, Dr. Reddy's and Viatris
Apr 18 TEVA 3 Generic Drug Stocks to Watch Amid Challenging Market Prospects
Apr 18 ITCI Intra-Cellular Therapies drops 2%, prices $500M equity financing
Apr 18 PRTC PureTech Health: Notice of Results
Apr 18 ITCI Intra-Cellular Therapies Prices Public Offering of Common Stock
Apr 17 ITCI Biotech Leader Intra-Cellular Soars 23%, Breaks Out Past Latest Buy Point
Apr 17 ITCI Intra-Cellular (ITCI) Up as Depression Drug Meets Study Goals
Apr 17 ITCI Intra-Cellular (ITCI) Moves 23.3% Higher: Will This Strength Last?
Apr 17 ITCI Abbott Laboratories, U.S. Bancorp And 3 Stocks To Watch Heading Into Wednesday
Apr 16 TEVA FDA approves Alvotech biosimilar of J&J top-selling drug Stelara
Apr 16 TEVA Alvotech and Teva Announce U.S. FDA Approval of SELARSDI™ (ustekinumab-aekn), biosimilar to Stelara® (ustekinumab)
Apr 16 ITCI Intra-Cellular Therapies announces proposed public offering of common stock
Apr 16 ITCI Intra-Cellular Therapies Announces Proposed Public Offering of Common Stock
Apr 16 ITCI Intra-Cellular: More Upside Possible Even After Positive MDD Treatment Data
Apr 16 ITCI UnitedHealth Reports Upbeat Earnings, Joins Cullinan Oncology, Ericsson And Other Big Stocks Moving Higher On Tuesday
Apr 16 ITCI Intra-Cellular Therapies Stock Launches 20% Into Breakout Territory On Depression Test Results
Apr 16 ITCI Intra-Cellular Therapies gains on meeting main goal in trial for its depression treatment
Apr 16 TEVA Teva’s New Real-World Evidence Presented at the 2024 AAN Annual Meeting Confirms Effectiveness and Patient Satisfaction for HD Chorea with the 4-week Titration Kit for AUSTEDO® (deutetrabenazine) Tablets
Parkinson's Disease

Parkinson's disease (PD) is a long-term degenerative disorder of the central nervous system that mainly affects the motor system. The symptoms generally come on slowly over time. Early in the disease, the most obvious are shaking, rigidity, slowness of movement, and difficulty with walking. Thinking and behavioral problems may also occur. Dementia becomes common in the advanced stages of the disease. Depression and anxiety are also common, occurring in more than a third of people with PD. Other symptoms include sensory, sleep, and emotional problems. The main motor symptoms are collectively called "parkinsonism", or a "parkinsonian syndrome".The cause of Parkinson's disease is generally unknown, but believed to involve both genetic and environmental factors. Those with a family member affected are more likely to get the disease themselves. There is also an increased risk in people exposed to certain pesticides and among those who have had prior head injuries, while there is a reduced risk in tobacco smokers and those who drink coffee or tea. The motor symptoms of the disease result from the death of cells in the substantia nigra, a region of the midbrain. This results in not enough dopamine in these areas. The reason for this cell death is poorly understood, but involves the build-up of proteins into Lewy bodies in the neurons. Diagnosis of typical cases is mainly based on symptoms, with tests such as neuroimaging being used to rule out other diseases.There is no cure for Parkinson's disease, with treatment directed at improving symptoms. Initial treatment is typically with the antiparkinson medication levodopa (L-DOPA), with dopamine agonists being used once levodopa becomes less effective. As the disease progresses and neurons continue to be lost, these medications become less effective while at the same time they produce a complication marked by involuntary writhing movements. Diet and some forms of rehabilitation have shown some effectiveness at improving symptoms. Surgery to place microelectrodes for deep brain stimulation has been used to reduce motor symptoms in severe cases where drugs are ineffective. Evidence for treatments for the non-movement-related symptoms of PD, such as sleep disturbances and emotional problems, is less strong.In 2015, PD affected 6.2 million people and resulted in about 117,400 deaths globally. Parkinson's disease typically occurs in people over the age of 60, of which about one percent are affected. Males are more often affected than females at a ratio of around 3:2. When it is seen in people before the age of 50, it is called young-onset PD. The average life expectancy following diagnosis is between 7 and 14 years. The disease is named after the English doctor James Parkinson, who published the first detailed description in An Essay on the Shaking Palsy, in 1817. Public awareness campaigns include World Parkinson's Day (on the birthday of James Parkinson, 11 April) and the use of a red tulip as the symbol of the disease. People with Parkinson's who have increased the public's awareness of the condition include actor Michael J. Fox, Olympic cyclist Davis Phinney, and late professional boxer Muhammad Ali.

Browse All Tags